Continuous Glucose Monitoring in T1DM, Ticragelor vs DAPT in ACS, Nasal ACE2 Levels and COVID-19 in Children, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 16, 2020 issue